{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:46:39Z","timestamp":1792597599816,"version":"4.5.0"},"reference-count":9,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"abstract":"<jats:p>This Viewpoint explores the benefits of stated-preference methods for quantifying risk tolerance in kidney xenotransplantation.<\/jats:p>","DOI":"10.1001\/jamasurg.2026.4780","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:00:32Z","timestamp":1792594832000},"source":"Crossref","is-referenced-by-count":0,"title":["Quantifying Risk Tolerance in Kidney Xenotransplant\u2014From Clinical Trials to Clinical Practice"],"prefix":"10.1001","author":[{"given":"Tina","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen R.","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Surgery, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Marcos","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina"},{"name":"Duke Clinical Research Institute, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"McElroy","sequence":"additional","affiliation":[{"name":"Department of Population Health Sciences, Duke University School of Medicine, Durham, North Carolina"},{"name":"Department of Surgery, Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"2","key":"svp260017r1","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.ajt.2025.01.020","article-title":"OPTN\/SRTR 2023 annual data report: kidney.","volume":"25","author":"Lentine","year":"2025","journal-title":"Am J Transplant"},{"issue":"1","key":"svp260017r3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","article-title":"Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force.","volume":"16","author":"Reed Johnson","year":"2013","journal-title":"Value Health"},{"issue":"14","key":"svp260017r4","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71072","article-title":"Quantifying preferences for CAR-T compared to standard of care as a first-line treatment among patients with multiple myeloma.","volume":"14","author":"Sutphin","year":"2025","journal-title":"Cancer Med"},{"issue":"23","key":"svp260017r5","doi-asserted-by":"publisher","first-page":"7371","DOI":"10.1182\/bloodadvances.2023009680","article-title":"Preferences for potential benefits and risks for gene therapy in the treatment of sickle cell disease.","volume":"7","author":"Gonzalez Sepulveda","year":"2023","journal-title":"Blood Adv"},{"issue":"9","key":"svp260017r6","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.2215\/CJN.01480222","article-title":"Patient preferences for waiting time and kidney quality.","volume":"17","author":"Mehrotra","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"svp260017r7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ajt.2025.10.005","article-title":"Beyond theory and into practice: a qualitative study of the experiences of xenotransplant recipients.","volume":"26","author":"Levan","year":"2026","journal-title":"Am J Transplant"},{"issue":"5","key":"svp260017r8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1053\/j.ajkd.2021.08.021","article-title":"Challenges to shared decision making about treatment of advanced CKD: a qualitative study of patients and clinicians.","volume":"79","author":"House","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"svp260017r9","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1053\/j.ajkd.2023.09.019","article-title":"Engineering equity into the promise of xenotransplantation.","volume":"83","author":"Reese","year":"2024","journal-title":"Am J Kidney Dis"},{"key":"svp260017r2","unstructured":"Center for Devices and Radiological Health, Center for Biologics Evaluation and Research. Incorporating voluntary patient preference information over the total product life cycle. US Food and Drug Administration. Accessed June 9, 2026. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/incorporating-voluntary-patient-preference-information-over-total-product-life-cycle"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2855644\/jamasurgery_cheng_2026_vp_260017_1792008173.34631.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:00:32Z","timestamp":1792594832000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2855644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":9,"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2026.4780","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,21]]}}}